Monitoring proves better than active treatment for low-risk prostate cancer

Men over 60 with low-risk prostate cancer could spend ten years with no active treatment, have a better sex life as a result, yet still be very unlikely to die from the disease, new research has found.

Tue, 12 Jul 2022
Prostate CancerActive Surveillance

The findings come from two new studies looking at ‘active surveillance’ of prostate cancer – when the disease is closely monitored but not treated – presented at the 2021 European Association of Urology congress today.